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Enantioselective Synthesis of the Platensimycin Core by Silver(I)-
Promoted Cyclization of ∆6-α-Iodoketone  
Milos Trajkovic,[a] Zorana Ferjancic,[a] Radomir N. Saicic* [a,b] and Filip Bihelovic* [a] 
Abstract: A chiral pool based synthesis of the platensimycin core 
was achieved using (S)-lactic acid as an inexpensive starting 
material. The cyclohexenone ring was closed in a Mukaiyama-
Michael domino sequence, while the quaternary stereocenter was 
created by a highly stereoselective decarboxylative allylation. The 
spirobicyclic skeleton was constructed by RCM reaction. A new 
silver(I)-promoted cyclization reaction of ∆6- and ∆7-α-iodoketones 
was developed and applied for the pivotal carbon-carbon bond 
formation. The scope and limitations of this methodology are also 
presented. 
The development of bacterial resistance to first-line antibiotic 
drugs1 urged scientific community to search for new drug 
candidates.2 These efforts involved, inter alia, the synthesis of 
new antibiotic compounds, as well as structural modifications of 
the existing ones.3  Consequently, new synthetic strategies are 
constantly emerging, aiming at more efficient and flexible 
syntheses necessary for SAR studies (of the analogues).4 In 
2006, platensimycin was isolated from a Streptomyces platensis 
strain, showing strong in vitro antibacterial activity toward broad-
spectrum Gram-positive bacteria, including methicillin-resistant 
Staphylococcus Aureus (MRSA), vancomycin-intermediate S. 
aureus (VISA), and vancomycin-resistant Enterococci (VRE).5 
More importantly, it shows in vivo activity without toxicity, 
especially when administered directly into cells.6 However, due 
to a high rate of its clearance in the body, its pharmacokinetic 
properties have to be improved,7 which calls for the development 
of a flexible strategy for the synthesis of platensimycin 
analogues.  
For this reason and due to the complex and intricate structure of 
the platensimycin core, a number of enantioselective and 
racemic (total and formal) syntheses have been reported so far.8 
We set out to develop an alternative and flexible synthesis of the 
platenismycin core relying on a chiral pool strategy, thus 
potentially enabling the synthesis of its analogues by simply 
changing the structures of the reactants. 
Scheme 1. Retrosynthetic analysis of the platensimycin core 
 
Our retrosynthetic analysis of the platensimycin core is shown in 
Scheme 1. It started with the C-O bond disconnection of the 
tetrahydrofuran ring in 1 through the etherification transform. 
The formation of the tricyclic skeleton 2 was considered to be 
one of the key steps in the synthesis and this was planned to be 
achieved through epoxide 3 opening by a ketone enolate. This 
spirobicyclic system would be a product of the ring closing 
metathesis reaction of diene 4, potentially obtainable by 
stereoselective decarboxylative allylation of allyl/methallyl 
diester 5. Cyclohexenone 5 could be synthesized by Diels Alder 
reaction of Danishefsky’s diene 6 and chiral alkylidenemalonate 
7 – a product of the Knoevenegel condensation of malonic ester 
with the optically pure (S)-lactic acid derivative. We believed that 
the absolute configuration of the chiral dienophile could dictate 
the absolute configuration of the newly-created stereogenic 
centre via the diastereoselective Diels Alder reaction, while all 
other stereocenters could be established in the course of the 
synthesis through the substrate control. 
 
The synthesis commenced with the preparation of the optically 
pure diallyl alkylidene malonate 10a9 – a reactive partner for the 
Yb-catalyzed Diels Alder reaction with Danishefsky’s diene 6 
(Scheme 2).10 Indeed, the reaction of 10a with 6 provided 
cyclohexenone 11a as a single isomer, but this transformation 
turn out to proceed by a different mechanism. The product 11a 
was actually formed by the Mukaiyama-Michael tandem 
reaction:11 the corresponding acyclic intermediate could be 
isolated when the reaction was performed at ambient 
temperature. Notably, the reaction proceeded with a complete 
diastereoselectivity, and the chiral information was successfully 
transferred from the starting (S)-lactic acid to the product, which 
was crucial for the enantioselective synthesis. 
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Scheme 2. Synthesis of the cyclohexene ring and diastereoselective 
decarboxylative allylation. Reagents and conditions: a) TiCl4, Pyr, THF, 0 °C to 
rt; b) Danishefsky’s diene 6, Yb(OTf)3, PhMe, rt to 120 °C; c) NaBH4, MeOH, 0 
°C  (dr = 19:1); d) [Pd(PPh3)4], CH2Cl2, rt; e) NaH, BnBr, TBAI, THF. 
The next task in the synthesis was Pd-catalyzed decarboxylative 
allylation,12 which was initially tested on cyclohexenone 11a. 
However, a complex mixture of products resulted under different 
reaction conditions, and after extensive experimentation we 
found that it was necessary to lower the substrate reactivity by 
the carbonyl group reduction. Free allylic alcohol 12a turned out 
to be an excellent substrate for this transformation and after 
treatment with [Pd(PPh3)4] the wanted product 13a was isolated 
in 92% yield, as a single diastereoisomer. The remarkable level 
of stereoselectivity is most probably a consequence of a steric 
environment on the neighboring carbon atom, bearing a bulky 
substituent. Encouraged by the completely diastereoselective 
formation of the new quaternary stereocenter, the whole 
sequence was repeated with bismethallyl homologue 10b. This 
proceeded uneventfully, and free allylic alcohol 13b was then 
protected as benzyl ether: the entire sequence was performed 
on a large scale, supplying us with 6 g of benzyl ether 14 in 77% 
overall yield (after 5 steps, from dimethallylmalonate 8b).  
According to our retrosynthetic analysis, the bicyclic 
intermediate should be synthesized by a ring closing metathesis. 
To this end, ester 14 was transformed to the corresponding 
aldehyde 15 in two-steps (Scheme 3). 
Scheme 3. Synthesis of the spirobicyclic key intermediate 19. Reagents and 
conditions: a) Dibal-H, Et2O, -50 °C; b) DMP, CH2Cl2; c) CH2=CHMgBr, Et2O; 
d) Ac2O, Et3N, DMAP, CH2Cl2; e) Pd(OAc)2, Ph3P, Et3N, HCO2H, THF; f) 2nd 
generation Grubbs catalyst, CH2Cl2; g) HF·Pyr, THF; h) DMP, CH2Cl2. 
The addition of vinylmagnesium bromide afforded a 
diastereomeric mixture of allylic alcohols, which were 
subsequently acetylated (16). The deoxygenation of allylic 
acetate 16 proceeded in almost quantitative yield,13 leading to 
the formation of the metathesis precursor 17. The second 
generation Grubbs catalyst effected this spirocyclization with 
high efficiency.14 Finally, the TBS group in 18 was removed and 
the free alcohol was oxidized to yield methylketone 19 in 56% 
overall yield (over 8 steps, starting from diester 14). 
 
With gram quantities of the key bicyclic intermediate 19 in hand, 
the stage was set for the crucial Cα-C3 bond formation. However, 
we were unable to accomplish the intramolecular epoxide 
opening by ketone enolate on the 3-like substrates, even in the 
presence of Lewis acids.15  
Another complementary strategy relied on radical cyclizations: 
the functionalization of methyl ketone 19 in the α-position 
afforded the corresponding xanthate (or iodide) which, under 
either thermal or photochemical conditions, cyclized only 
sluggishly, yielding an equimolar mixture of the two regioisomers 
(Cα-C3 and Cα-C2). Encouraged with these initial results, we 
wanted to test whether the yield as well as the regioselectivity of 
the addition could be improved by switching the neutral radical 
conditions for the ionic ones. To this end, we prepared ∆6-α-
iodoketone 20 (Scheme 4) as a model substrate, assuming that 
silver(I) salts could promote the desired cyclization. Much to our 
pleasure, the reaction indeed worked and, after optimization of 
the reaction conditions, we found that the highest yield of the 
cyclized product could be obtained with silver(I) 
trifluoromethanesulfonate in CH2Cl2. This unprecedented 
cyclization can be perfomed either in the absence or in the 
presence of 2,6-lutidine, resulting in the formation of conjugated 
cyclohexenone (21), or cyclohexanone (22 and 23), respectively. 
Scheme 4. Silver(I)-promoted cyclization of ∆6-α-iodoketone 20. Reagents 
and conditions: a) AgOTf, CH2Cl2, rt, 30 min; b) AgOTf, 2,6-lutidine, CH2Cl2, rt, 
15 min (22:23 = 1:1). 
 
The scope of the reaction was tested on several substrates, and 
the representative results are summarized in Table 1. The 
reaction allowed for the smooth synthesis of cyclohexanone 
(entries 1-5) and cycloheptanone (entry 6) derivatives in good to 
excellent yields, without formation of any side product, thus 
simplifying the purification/isolation steps.  
It was surprising to witness the inertness of ∆5-α-iodoketones 
toward cyclization,16 or even toward decomposition of the 
starting material after prolonged reaction time (48 h). Moreover, 
it proved necessary for all the substrates to possess a 
trisubstituted double bond. The stability of ∆5-α-iodoketones 
under the reaction conditions ruled out a formation of the 
energy-rich α-acylcarbenium ions intermediates,17 as its 
irreversible formation (AgI precipitation) would result in the 
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disappearance of the starting material. Therefore, we believe 
that the reaction might proceed via a reversible silver(I) 
complexation to the double bond, with a simultaneous formation 
of the C-C bond and AgI. 
 
Entry Substrate Product Reaction Conditions 
Isolated 
Yields 
1 
  AgOTf 
(1.5 eq) 
2,6-lutidine 
(1.2 eq), 15 
min, rt 
72% 
2 
  
AgOTf 
(1.5 eq), 30 
min, rt 
74% 
3 
  
AgOTf 
(1.2 eq) 
2,6-lutidine 
(1.3 eq), 2 
h, rt 
89% 
4 
  AgOTf 
(1.2 eq), 30 
min, rt 
90% 
5 
 
 
AgOTf 
(1.5 eq) 
2,6-lutidine 
(1.7 eq), 
overnight, rt 
88% 
6 
  
AgOTf 
(1.5 eq) 
2,6-lutidine 
(1.2 eq), 7 
h, rt 
67% 
Table 1: Representative examples of AgOTf promoted cyclization of ∆6- and 
∆7-α-iodoketones  
 
The reaction proceeds via the carbocationic intermediate, as 
demonstrated by its trapping with methanol (Scheme 5). While 
∆6- and ∆7-α-iodoketones can attain a geometrically favorable 
transition state conformation, ∆5-α-iodoketones most probably 
cannot. Intramolecular carbocation trapping by either the OH 
group or by another suitably positioned double bond could lead 
to more complex polycyclic products, and the results of this 
study will be published in due course. 
Scheme 5. A plausable mechanistic pathway for Ag(I)-promoted cyclization of 
∆6- and ∆7-α-iodoketones  
 
We then applied the optimized cyclization conditions to α-
iodoketone 35, and much to our delight a smooth cyclization 
occurred within minutes, affording the key tricyclic product 36 in 
almost quantitative yield (Scheme 6).  
Scheme 6. Synthesis of the tetracyclic platensimycin core 1. Reagents and 
conditions: a) TMSOTf, DIPEA, CH2Cl2, 0 °C, then NIS, CH2Cl2, -78 °C; b) 
AgOTf, 2,6-lutidine, CH2Cl2, rt; c) NaBH4, CeCl3, MeOH, -78 °C; d) 
ClCH2SO2Cl, Pyr, DMAP, CH2Cl2; e) CsOAc, 18-crown-6, PhH; f) K2CO3, 
MeOH, H2O; g) NBS, CH2Cl2, -40 °C; h) TBTH, AIBN, PhH, hν (Xenophot); i) 
Li-naphthalenide, THF, -25 °C; j) DMP, CH2Cl2.  
 
It was necessary to perform the reaction in the presence of 2,6-
lutidine: in its absence the starting material/product decomposed 
quickly due to the release of triflic acid. In the next step of the 
synthesis, the reduction of the carbonyl group could not be 
achieved with a satisfying level of diastereoselectivity, as the 
unwanted diastereomer was obtained either as a major or as a 
single product, under various reduction conditions. Therefore, 
we relied on a two-step strategy comprising the inversion of 
configuration of the opposite alcohol diastereomer 37, obtained 
almost exclusively by the Luche reduction of 36. Unfortunately, 
this inversion could not be performed by the standard Mitsunobu 
protocol, probably due to considerable steric hindrance of the 
OH-group in the starting alcohol. As an alternative, the alcohol 
37 was first converted to the corresponding chloromesylate 
which was treated with CsOAc/18-crown-6,18 to afford the 
inverted acetate 38. After the hydrolysis of acetate 38, the fourth 
(tetrahydrofuran) ring remains to be closed. Contrary to the 
results of the other groups, this etherification could not be 
catalyzed by acids due to the liability of the allylic fragment. 
However, bromoetherification/radical debromination strategy 
allowed for the formation of tetracycle 40 in 92% yield. 
Debenzylation of 40 with lithium naphthalenide,19 followed by 
DMP oxidation of allylic alcohol 41,20 afforded the target 
platensimycin core 1, with all physical and spectral 
characteristics identical to those previously reported in the 
literature.5a 
In summary, we exploited a chiral pool strategy for the 
enantioselective synthesis of the platensimycin core. The 
Mukaiyama-Michael domino reaction successfully transferred 
the chiral information from the (S)-lactic acid derivative to the 
cyclohexenone product. A palladium-catalyzed decarboxylative 
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allylation enabled the proper stereochemistry of the quaternary 
stereocenter to be set. The crucial C-C bond was formed 
efficiently, under mild reaction conditions by a newly-developed 
method for the cyclization of ∆6- and ∆7-α-iodoketones with 
silver(I) salts, which is complementary to radical methodology, 
and may have general applicability. 
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